MetaCap

Armata Pharmaceuticals Statistics

NYSE: ARMPHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

3.03+0.05 (+1.68%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Armata Pharmaceuticals by the numbers

Armata Pharmaceuticals has a market capitalization of $112.7 million based on 37.19M shares outstanding. With trailing EPS of $-4.17, Armata Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 14.4% below its 50-day average and 55.2% below its 200-day average.

Average daily trading volume is 182.52K shares, or about $553,030 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

ARMP valuation vs. peer median

ARMP compared with the median of 8 peer companies
MetricARMPPeer medianDifference
Market cap$112.69M$114.21M-1%
Avg. volume182.52K1.37M-87%

Peer median across 8 companies: FATE, CRDL, ENGN, IVVD, HUMA, CMPX, MOLN, IPHA.

Valuation

Price and trading

Previous close
2.98
Open
2.92
Day range
2.89 – 3.19
52-week range
2.40 – 14.98
52-week change
-56.90%
Beta
—
Volume
85.64K

Dividends and events

Annual dividend
None
Next earnings date
Nov 12, 2026

Additional statistics

Market Cap
112.69M
Forward Pe
-1.49
Eps
-4.17
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
14.98
Week52 Low
2.40
Avg Volume
182.52K
Shares Outstanding
37.19M
Ma50
3.54
Ma200
6.76
Earnings Date
Nov 12, 2026
Pct From52w High
-79.77%
Pct From52w Low
26.25%

Related